ModivCare PE Ratio 2010-2024 | MODV
Current and historical p/e ratio for ModivCare (MODV) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ModivCare PE ratio as of November 22, 2024 is 13.79.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ModivCare PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-11-21 | 17.47 | 0.00 | |
| 2024-09-30 | 14.28 | $-12.88 | 0.00 |
| 2024-06-30 | 26.24 | $-11.31 | 0.00 |
| 2024-03-31 | 23.45 | $-15.71 | 0.00 |
| 2023-12-31 | 43.99 | $-14.42 | 0.00 |
| 2023-09-30 | 31.51 | $-14.54 | 0.00 |
| 2023-06-30 | 45.21 | $-16.27 | 0.00 |
| 2023-03-31 | 84.08 | $-2.56 | 0.00 |
| 2022-12-31 | 89.73 | $-2.26 | 0.00 |
| 2022-09-30 | 99.68 | $-4.02 | 0.00 |
| 2022-06-30 | 84.50 | $-2.53 | 0.00 |
| 2022-03-31 | 115.39 | $-1.81 | 0.00 |
| 2021-12-31 | 148.29 | $-2.05 | 0.00 |
| 2021-09-30 | 181.62 | $2.70 | 67.27 |
| 2021-06-30 | 170.07 | $2.26 | 75.25 |
| 2020-12-31 | 138.63 | $2.30 | 60.27 |
| 2020-09-30 | 92.91 | $1.97 | 47.16 |
| 2020-06-30 | 78.91 | $0.78 | 101.17 |
| 2020-03-31 | 54.88 | $2.23 | 24.61 |
| 2019-12-31 | 59.18 | $1.01 | 58.59 |
| 2021-03-31 | 148.12 | $1.52 | 97.45 |
| 2019-09-30 | 59.46 | $-1.46 | 0.00 |
| 2019-06-30 | 57.34 | $-1.52 | 0.00 |
| 2019-03-31 | 66.62 | $-2.25 | 0.00 |
| 2018-12-31 | 60.02 | $-1.92 | 0.00 |
| 2018-09-30 | 67.28 | $2.16 | 31.15 |
| 2018-06-30 | 78.55 | $2.63 | 29.87 |
| 2018-03-31 | 69.14 | $3.76 | 18.39 |
| 2017-12-31 | 59.34 | $3.07 | 19.33 |
| 2017-09-30 | 54.08 | $5.58 | 9.69 |
| 2017-06-30 | 50.61 | $4.65 | 10.88 |
| 2017-03-31 | 44.44 | $4.68 | 9.50 |
| 2016-12-31 | 38.05 | $5.15 | 7.39 |
| 2016-09-30 | 48.63 | $4.30 | 11.31 |
| 2016-06-30 | 44.88 | $3.94 | 11.39 |
| 2016-03-31 | 51.07 | $3.99 | 12.80 |
| 2015-12-31 | 46.92 | $4.24 | 11.07 |
| 2015-09-30 | 43.58 | $0.62 | 70.29 |
| 2015-06-30 | 44.28 | $1.05 | 42.17 |
| 2015-03-31 | 53.12 | $1.25 | 42.50 |
| 2014-12-31 | 36.44 | $1.37 | 26.60 |
| 2014-09-30 | 48.38 | $1.16 | 41.71 |
| 2014-06-30 | 36.59 | $1.39 | 26.32 |
| 2014-03-31 | 28.28 | $1.36 | 20.79 |
| 2013-12-31 | 25.72 | $1.41 | 18.24 |
| 2013-09-30 | 28.69 | $1.39 | 20.64 |
| 2013-06-30 | 29.09 | $1.23 | 23.65 |
| 2013-03-31 | 18.49 | $0.91 | 20.32 |
| 2012-12-31 | 16.99 | $0.65 | 26.14 |
| 2012-09-30 | 12.99 | $0.65 | 19.98 |
| 2012-06-30 | 13.71 | $0.71 | 19.31 |
| 2012-03-31 | 15.51 | $0.96 | 16.16 |
| 2011-12-31 | 13.76 | $1.07 | 12.86 |
| 2011-09-30 | 10.65 | $1.18 | 9.03 |
| 2011-06-30 | 12.65 | $1.25 | 10.12 |
| 2011-03-31 | 14.98 | $1.43 | 10.48 |
| 2010-12-31 | 16.07 | $1.75 | 9.18 |
| 2010-09-30 | 16.39 | $1.84 | 8.91 |
| 2010-06-30 | 14.00 | $1.96 | 7.14 |
| 2010-03-31 | 15.19 | $1.82 | 8.35 |
| 2009-12-31 | 15.80 | $1.60 | 9.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.254B | $2.756B |
| ModivCare Inc. is a technology-enabled healthcare services company. It provides a suite of integrated supportive care solutions for public and private payors and their patients. ModivCare Inc., formerly known as The Providence Service Corporation, is based in DENVER. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $93.361B | 11.58 |
| Cencora (COR) | United States | $48.280B | 17.81 |
| DiDi Global (DIDIY) | China | $22.212B | 0.00 |
| Natera (NTRA) | United States | $22.082B | 0.00 |
| ICON (ICLR) | Ireland | $17.675B | 15.74 |
| Viatris (VTRS) | United States | $15.958B | 4.92 |
| Avantor (AVTR) | United States | $14.143B | 21.20 |
| Revvity (RVTY) | United States | $13.634B | 23.68 |
| CochLear (CHEOY) | Australia | $12.777B | 0.00 |
| Solventum (SOLV) | United States | $12.233B | 0.00 |
| BioMerieux (BMXMF) | France | $11.895B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.498B | 29.58 |
| Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
| HealthEquity (HQY) | United States | $9.104B | 49.41 |
| Doximity (DOCS) | United States | $8.999B | 52.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
| Life Times (LTH) | United States | $5.081B | 33.63 |
| Organon (OGN) | United States | $3.935B | 3.97 |
| Sotera Health (SHC) | United States | $3.631B | 19.42 |
| BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
| Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
| Concentras Parent (CON) | United States | $2.789B | 0.00 |
| PACS (PACS) | United States | $2.515B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
| Premier (PINC) | United States | $2.195B | 11.42 |
| GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
| Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
| Progyny (PGNY) | United States | $1.315B | 26.62 |
| Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
| CareDx (CDNA) | United States | $1.241B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
| Embecta (EMBC) | United States | $0.797B | 5.32 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.779B | 0.00 |
| SBC Medicals (SBC) | United States | $0.674B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| DocGo (DCGO) | United States | $0.434B | 16.35 |
| Enhabit (EHAB) | United States | $0.380B | 32.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
| LifeMD (LFMD) | United States | $0.251B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
| Biodesix (BDSX) | United States | $0.186B | 0.00 |
| Nutex Health (NUTX) | United States | $0.179B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| MultiPlan (MPLN) | United States | $0.112B | 0.00 |
| So-Young (SY) | China | $0.086B | 16.60 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.10 |
| IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |